title: Is GABA neurotransmission enhanced in auditory thalamus relative to inferior colliculus?
abstract: Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central auditory system. Sensory thalamic structures show high levels of non-desensitizing extrasynaptic GABAA receptors (GABAARs) and a reduction in the redundancy of coded information. The present study compared the inhibitory potency of GABA acting at GABAARs between the inferior colliculus (IC) and the medial geniculate body (MGB) using quantitative in vivo, in vitro, and ex vivo experimental approaches. In vivo single unit studies compared the ability of half maximal inhibitory concentrations of GABA to inhibit sound-evoked temporal responses, and found that GABA was two to three times (P < 0.01) more potent at suppressing MGB single unit responses than IC unit responses. In vitro whole cell patch-clamp slice recordings were used to demonstrate that gaboxadol, a δ-subunit selective GABAAR agonist, was significantly more potent at evoking tonic inhibitory currents from MGB neurons than IC neurons (P < 0.01). These electrophysiological findings were supported by an in vitro receptor binding assay which used the picrotoxin analog [(3)H]TBOB to assess binding in the GABAAR chloride channel. MGB GABAARs had significantly greater total open chloride channel capacity relative to GABAARs in IC (P < 0.05) as shown by increased total [(3)H]TBOB binding. Finally, a comparative ex vivo measurement compared endogenous GABA levels and suggested a trend towards higher GABA concentrations in MGB than in IC. Collectively, these studies suggest that, per unit GABA, high affinity extrasynaptic and synaptic GABAARs confer a significant inhibitory GABAAR advantage to MGB neurons relative to IC neurons. This increased GABA sensitivity likely underpins the vital filtering role of auditory thalamus.
authors.affiliation: Southern Illinois University School of Medicine, Department of Pharmacology, Springfield, Illinois; and.
authors.forename: Rui
authors.initials: R
authors.lastname: Cai
authors.forename: Bopanna I
authors.initials: BI
authors.lastname: Kalappa
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Brozoski
authors.forename: Lynne L
authors.initials: LL
authors.lastname: Ling
authors.forename: Donald M
authors.initials: DM
authors.lastname: Caspary
mesh_terms: D000818:Animals; D002712:Chlorides / Q000378:metabolism; D058785:GABA-A Receptor Agonists / Q000494:pharmacology; D059330:GABAergic Neurons / Q000378:metabolism / Q000502:physiology*; D005829:Geniculate Bodies / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D007245:Inferior Colliculi / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D007555:Isoxazoles / Q000494:pharmacology; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D020318:Rats, Long-Evans; D011963:Receptors, GABA-A / Q000378:metabolism; D013569:Synapses / Q000378:metabolism / Q000502:physiology; D055366:Synaptic Potentials; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
chemical_list: D002712:Chlorides; D058785:GABA-A Receptor Agonists; D007555:Isoxazoles; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid; C015542:gaboxadol
keywords: GABAA receptor; gamma-aminobutyric acid; inferior colliculus; medial geniculate body